Alfen Beheer Correlations

ALFEN Stock  EUR 11.55  0.22  1.94%   
The current 90-days correlation between Alfen Beheer BV and Pharming Group NV is 0.38 (i.e., Weak diversification). The correlation of Alfen Beheer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Alfen Beheer Correlation With Market

Significant diversification

The correlation between Alfen Beheer BV and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alfen Beheer BV and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Alfen Beheer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alfen Beheer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alfen Beheer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alfen Beheer BV to buy it.

Moving together with Alfen Stock

  0.72ASML ASML Holding NVPairCorr

Moving against Alfen Stock

  0.49REN Relx PLCPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AMGPHARM
  
High negative correlations   
BESIPHARM
BESIAMG

Risk-Adjusted Indicators

There is a big difference between Alfen Stock performing well and Alfen Beheer Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alfen Beheer's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Alfen Beheer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Alfen Beheer Corporate Management

Elected by the shareholders, the Alfen Beheer's board of directors comprises two types of representatives: Alfen Beheer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alfen. The board's role is to monitor Alfen Beheer's management team and ensure that shareholders' interests are well served. Alfen Beheer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alfen Beheer's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michelle LeshChief OfficerProfile
Willem AckermansIndependent Member of the Supervisory BoardProfile
Eline OudenbroekIndependent Member of the Supervisory BoardProfile
Adriaan TetsDirector MangProfile